This edition covers all things mHealth ranging from real time data collection in a heart disease study, the pros and cons of different mHealth management approaches, keys to going mobile in pharma, app prescribing and likely discussions coming from the upcoming release of the FDA’s mobile medical apps guidelines:

– iHealthBeat’s Heart Disease Study Will Leverage Smartphones To Pull Real-Time Data outlines an initiative, called the Health eHeart Study, which will use smartphone applications, digital sensors and other devices to collect in real time data

– When WebMD looks at developing mobile technology, they break it down into three “modalities” or sub-technologies, all available through a mobile phone; mobile web, text messaging, and native applications. The Pros & Cons of Different Mobile Health Management Approaches provides their answer to the question “which is the best mobile approach for the health & wellness space?”

– Based on years of experience in deploying apps, 5 industry experts shared what they have learned during a FiercePharma webinar sponsored by Kony –  5 Keys to Going Mobile in Pharma. The webinar covered a good deal of ground from the main areas of the pharma industry –  including drug discovery, development and marketing.

-App prescribing offers an unprecedented opportunity to increase patient engagement and improve care management. App Prescribing: The Future of Patient-Centered Care from The Health Care Blog introduces Happtique Health App Certification Program (HACP) which will test health apps against a set of published standards and performance requirements that encompass operability, privacy, security, and content

– The FDA recently shared that the final mobile medical apps guidance should be out by October 1, 2013. MobiHealthNews’ After FDA’s Mobile Medical Apps Final Guidance, What’s Next?  highlights a dozen issues that will likely dominate the regulatory policy discussions around mHealth for the balance of 2013 and beyond

That wraps this week’s review of news from and for the pharma market research community. I’ll leave you with an invitation to learn more about the benefits of real time data  and offer you a personal demo of InCrowd’s on-demand platform  providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.

If you have tips, suggestions, or resources you’d like to share leave us a comment below and please feel free to suggest topics that you would like to see covered in future posts.